Insights & Resources | Pfizer CentreOne

Pfizer CentreOne Newsletter January 2021 Edition

At Pfizer CentreOne, we are proud of the trust you placed in our organization, whether it’s for securing your API or intermediates supply, or developing and commercializing your products. Together with you, we draw inspiration from our purpose to help patients in need, and that has never been more important than it is now.

The Power of People: What I Learned About My Team

The foundation of any great team is the strong connection among its members. I started my role as the GM of Pfizer CentreOne during the pandemic and was concerned about establishing relationships virtually. Two months later, I have yet to meet any of my team members face-to-face. However, the connections I’ve already made across the team are strong and they have made quite the impression.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Pfizer CentreOne's Partnership Promise

Strong commercial partnerships are based on trust and lasting relationships. For this reason, organizational changes can be unsettling. What will the new leader bring? What impact will the change have on my partnership? These are valid questions that should be addressed.

Infographic | Embedded CDMO Misconceptions

Access to the expert capabilities of embedded CDMOs is offering great economies and competitive experience. However, embedded CDMOs are still surrounded by misconceptions. In this infographic, Karen Lauxmann, Contract Manufacturing European Sales Lead, addresses 8 of the most common misconceptions we encounter at Pfizer CentreOne as an embedded CDMO.

Experience the Art of Science - Stefano Petracci's story

In our latest ‘Experience the Art of Science’ blog post, we meet Stefano Petracci, Technical Project Manager at our Ascoli facility and an accomplished artist.

Starting your sterile injectables program off on the right foot

How can drug sponsors and developers leverage these increasingly strategic commercial fill/finish partnerships? Product development experts Jennifer Quint and Daniel Lenz at Pfizer CentreOne offer their tips on how drug sponsors and developers can put programs on a firmer footing.

Experience the Art of Science - Norman Jansen's story

In this first instalment of our ‘Experience the Art of Science’ blog series, we meet Norman Jansen, Senior Research Advisor at our Kalamazoo facility and a keen photographer in his spare time.

Quality Attributes For Strategic Small Molecule API Partners

Tom Wilson, Contract Manufacturing Lead at Pfizer CentreOne, offers insights for picking small molecule development and manufacturing partners based on the following strategic quality attributes (SQAs):

Five Dangers of an Insecure API Supply Chain

In this e-book Ken Ball, Commercial Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses five dangers of an insecure API supply chain.

Top Four Considerations for Tech Transfer Performance

Whether you are a drug developer searching for a CDMO partner for the first time, rising to a new role, or a veteran scrambling to fill a gap in your supply chain, there are four key considerations for gauging strong technology transfer performance: geographic footprint, technology, regulatory compliance, and talent.